KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Liabilities and Shareholders Equity (2021 - 2025)

Crescent Capital BDC (CCAP) has disclosed Liabilities and Shareholders Equity for 5 consecutive years, with $1.6 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity fell 1.06% year-over-year to $1.6 billion, compared with a TTM value of $4.9 billion through Dec 2025, down 24.95%, and an annual FY2024 reading of $1.7 billion, up 1.78% over the prior year.
  • Liabilities and Shareholders Equity was $1.6 billion for Q3 2025 at Crescent Capital BDC, down from $1.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.7 billion in Q2 2024 and bottomed at $1.3 billion in Q4 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2025.
  • The sharpest move saw Liabilities and Shareholders Equity rose 21.3% in 2023, then fell 1.08% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $1.3 billion in 2021, then increased by 1.63% to $1.3 billion in 2022, then grew by 21.51% to $1.6 billion in 2023, then grew by 1.78% to $1.7 billion in 2024, then fell by 1.73% to $1.6 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for CCAP at $1.6 billion in Q3 2025, $1.7 billion in Q2 2025, and $1.7 billion in Q1 2025.